| CEP-18770 |
CEP-18770 |
847499-27-8 |
| NVP-BEP800 |
NVP-BEP800;2-AMINO-4-(2,4-DICHLORO-5-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE |
847559-80-2 |
| ICG-001 |
ICG-001 |
847591-62-2 |
| ML385 |
ML385 |
846557-71-9 |
| Z-360 |
NASTORAZEPIDE |
209219-38-5 |
| DAPT |
DAPT |
208255-80-5 |
| Tariquidar |
N-[2-[[4-[2-(6,7-二甲氧基-3,4-二氢-1H-异喹啉-2-基)乙基]苯基]氨基甲酰基]-4,5-二甲氧基苯基]喹啉-3-甲酰胺 |
206873-63-4 |
| METHYL 2-AMINO-5-BROMO-3-METHYLBENZENECARBOXYLATE |
2-氨基-5-溴-3-甲基苯甲酸甲酯 |
206548-14-3 |
| Liraglutide |
利拉鲁肽 |
204656-20-2 |
| Tecadenoson |
Tecadenoson |
204512-90-3 |
| (R)-1-N-BOC-BETA-PROLINE |
(R)-1-BOC-3-吡咯烷甲酸 |
202931-85-9 |
| 1-(2,4-DICHLOROPHENYL)-5-(4-IODOPHENYL)-4-METHYL-N-4-MORPHOLINYL-1H-PYRAZOLE-3-CARBOXAMIDE |
1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺 |
202463-68-1 |
| JAK3 INHIBITOR I |
4-(4'-羟基苯基)氨基-6,7-二甲氧基喹唑啉 |
202475-60-3 |
| OTX015 |
OTX-015 |
202590-98-5 |
| 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-triMethyl-, (6R)- |
2 - ((6R)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F]的[1,2,4 |
202592-24-3 |
| 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-triMethyl-, (6S)- |
(6S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]噻唑并[4,3-A][1,4]二氮杂卓-6-乙酸 |
202592-23-2 |
| LY 341495 |
(2S)-2-氨基-2-[(1S,2S)-2-羧基环丙-1-基]-3-(吨-9-基)丙酸 |
201943-63-7 |
| 3-Chloro-4-(3-fluorobenzyloxy)aniline |
3-氯-4-(3-氟苄氧基)苯胺 |
202197-26-0 |
| BENZOTRIAZOL-1-YL-(2,4-DICHLORO-PHENYL)-METHANONE |
1-(2,4-DICHLOROBENZOYL)-1H-BENZOTRIAZOLE |
200626-61-5 |
| 2-ethoxycyclohex-2-en-1-one |
2-乙氧基-2-环己烯-1-酮 |
29941-82-0 |
